N. Watts

Real-world effectiveness of osteoporosis therapies for fracture reduction in post-menopausal women

S. Cummings, C. Cooper, N. Watts, 2018, Archives of Osteoporosis.

Factors associated with 5-year risk of hip fracture in postmenopausal women.

C. Kooperberg, J. Wactawski‐Wende, A. Aragaki, 2007, JAMA.

Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: The risedronate and alendronate (REAL) cohort study

S. Silverman, P. Delmas, N. Watts, 2006, Osteoporosis International.

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2014): Oral Communication Abstracts

E. Siris, F. Hooven, S. Gehlbach, 2014, Osteoporosis International.

Impact of Prevalent Fractures on Quality of Life: Baseline Results from the Global Longitudinal Study of Osteoporosis in Women Repository Citation

E. Siris, K. Saag, F. Hooven, 2022 .

Self-perception of fracture risk: what can it tell us?

S. Silverman, E. Siris, K. Saag, 2017, Osteoporosis International.

Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW).

D. Hosmer, A. Díez-Pérez, L. March, 2014, The Journal of clinical endocrinology and metabolism.

The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design

A. LaCroix, C. Cooper, S. Silverman, 2009, Osteoporosis International.

When, Where and How Osteoporosis-Associated Fractures Occur: An Analysis from the Global Longitudinal Study of Osteoporosis in Women (GLOW)

Nelson B. Watts, Steven Boonen, Jonathan D. Adachi, 2013, PloS one.